Quick Read Pfizer (PFE) trades at $26.18 with a 24/7 Wall St. price target of $32.92, implying 25.76% upside, driven by ...

Pfizer is an over-100-year-old drug company going through a rough patch, which has happened before.

BEIJING--When Li’s 83-year-old father with diabetes started coughing and complaining of body aches last month, the Beijing ...

A rare hantavirus outbreak on an Atlantic cruise ship has reignited conspiratorial Covid-era misinformation, with posts sharing files from Pfizer and the World Health Organization (WHO) as supposed ...

By Christy Santhosh May 28 (Reuters) - The U.S. FDA's advisory panel will meet and then vote on Thursday on whether COVID-19 ...

The Vaccines and Related Biological Products Advisory Committee (VRBPAC) also discussed the need to target the long-simmering ...

The race to greenlight a COVID-19 vaccine in the United States has entered its final sprint, with one leading candidate becoming the first to release preliminary results showing its vaccine is more ...

Drugmaker Pfizer said Friday that as government contracts come to an end, possibly by early next year, its COVID-19 vaccine will be sold for $110 to $130 per dose. This price model comes down to ...

COVID-19 vaccinations are rolling out in St. Johns County, with front-line health-care workers, long-term care facility residents, and first responders receiving some of the first doses. The Florida ...

AbbVie and Pfizer chart distinct paths in revenue growth, risk, and valuation. Explore how their financials and strategies ...